Examining the influence of clinician decision making on adherence to a clinical guideline

Psychiatric Services

Volumn 60, Issue 5, 2009, Pages 698-701

  Falzer, Paul R ^a   Garman, D Melissa ^b   Moore, Brent A ^c  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b State of Connecticut   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PROTOCOL; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RESIDENT; RISK FACTOR; SCHIZOPHRENIA; TREATMENT RESPONSE; VIGNETTE;

EID: 66249115297     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2009.60.5.698     Document Type: Article

References (15)

1. Chilvers R, Harrison G, Sipos A, et al: Evidence into practice: application of psychological models of change in evidence-based implementation. British Journal of Psychiatry 181:99-101, 2002
2. Dickey B, Normand S-LT, Eisen S, et al: Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences. Medical Care 44:827-834, 2006
3. Sernyak MJ, Dausey D, Desai R, et al: Prescribers' nonadherence to treatment guidelines for schizophrenia when prescribing neuroleptics. Psychiatric Services 54:246-248, 2003
4. Lehman AF, Steinwachs DM, Dixon LB, et al: Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 24:1-10, 1998
5. Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23:637-651, 1997
6. Pyne JM, McSweeney J, Kane HS, et al: Agreement between patients with schizophrenia and providers on factors of antipsychotic medication adherence. Psychiatric Services 57:1170-1178, 2006
7. Falzer PR, Moore BA, Garman DM: Incorporating clinical guidelines through clinician decision making: study protocol. Implementation Science 3:13, 2008
8. Guy W: ECDEU Assessment Manual for Psychopharmacology. DHEW pub no 76-338. Rockville, Md, US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 1976
9. Patel VL, Arocha JF, Kaufman DR: Diagnostic reasoning and medical expertise, in The Psychology of Learning and Motivation: Advances in Research and Theory, Vol 31. Edited by Medin DL. New York, Academic Press, 1994
10. Ascher-Svanum H, Faries DE, Zhu B, et al: Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry 67:453-460, 2006
11. Practice guideline for the treatment of patients with schizophrenia: American Psychiatric Association. American Journal of sychiatry 154(supp 4):1-63, 1997
12. Texas Implementation of Medical Algorithms. Austin, Texas Department of State Health Services, 2007. Available at www.dshs.state.tx.us/mhprograms/TIMA. shtm
13. Fayek M, Flowers C, Signorelli D, et al: Psychopharmacology: underuse of evidence-based treatments in psychiatry. Psychiatric Services 54:1453-1456, 2003
14. Patel VL, Arocha JF, Kaufman DR: Expertise and tacit knowledge in medicine, in Tacit Knowledge in Professional Practice: Researcher and Practitioner Perspectives. Edited by Sternberg RJ, Horvath JA. Mahwah, NJ, Erlbaum, 1999
15. Maier T: Evidence-based psychiatry: understanding the limitations of a method. Journal of Evaluation in Clinical Practice 12:325-329, 2006